$1.540
-0.025 (-1.60%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CVKD por análisis de gráficos similares
Alphio's CVKD stock price prediction model matches the current Cadrenal Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.53 (-0.77%). The 1-week path is $1.53 (-0.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cadrenal Therapeutics Inc?
Cadrenal Therapeutics Inc (CVKD) is currently not a good buy due to its low price of $1.54, which is significantly down 78.99% year-to-date, indicating substantial market skepticism. The RSI is at 23.316, suggesting the stock is oversold, but this could also indicate continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the company has reported consistent net losses, with the latest quarterly net income at -2,496,540 USD.
CVKD cerró en $1.54 el Friday, tras bajar -1.60%
Cadrenal Therapeutics Inc (CVKD) last closed at $1.54, losing -1.60%. These facts feed the 1-day and 1-week CVKD price prediction above.
Factores de la previsión
Los factores de la previsión de Cadrenal Therapeutics Inc (CVKD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CVKD, ordenadas por similitud.
Análisis de estacionalidad de CVKD
Historically the probability of a positive August return for CVKD is 0.00%. January offers the highest probability of a positive month at 75.41%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CVKD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $8.79 | $10.91 | $13.24 | +608.58% |
| Sep 2026 | $9.86 | $10.76 | $11.67 | +598.92% |
| Oct 2026 | $9.40 | $10.80 | $11.54 | +601.53% |
| Nov 2026 | $8.95 | $10.19 | $10.29 | +561.59% |
| Dec 2026 | $11.65 | $12.26 | $12.79 | +696.14% |
En 2026, se proyecta que Cadrenal Therapeutics Inc (CVKD) oscile entre $8.79 y $13.24.
Previsión mensual de Cadrenal Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $10.91, con un mínimo de $8.79 y un máximo de $13.24.
En Sep de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $10.76, con un mínimo de $9.86 y un máximo de $11.67.
En Oct de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $10.80, con un mínimo de $9.40 y un máximo de $11.54.
En Nov de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $10.19, con un mínimo de $8.95 y un máximo de $10.29.
En Dec de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $12.26, con un mínimo de $11.65 y un máximo de $12.79.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.